A Brief Intervention for Co-occurring Pain and Distress in Primary Care
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Chronic Pain
- Sponsor
- Henry Ford Health System
- Enrollment
- 61
- Locations
- 1
- Primary Endpoint
- Hospital Anxiety and Depression Scale
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
The purpose of this research study is to investigate potential benefits of a behavioral intervention for co-occurring chronic pain and distress that is delivered in a primary care clinic.
Investigators
Lisa Matero
Senior Staff Psychologist
Henry Ford Health System
Eligibility Criteria
Inclusion Criteria
- •Chronic pain condition
- •A current patient within the Henry Ford Health System Academic Internal Medicine Clinic in Detroit
- •Has been within the Henry Ford Health System for at least 6 months
Exclusion Criteria
- •Current behavioral health treatment
Outcomes
Primary Outcomes
Hospital Anxiety and Depression Scale
Time Frame: 5 weeks post-baseline
This measure assesses the severity of depression and anxiety. Scores on each of the subscale (e.g., depression and anxiety) range from 0-21 with higher scores indicating greater severity.
Brief Pain Inventory
Time Frame: 5 weeks post-baseline
The Brief Pain Inventory measures pain severity and pain functioning. Pain severity is comprised of 4 questions on a 0-10 scale for pain at it's worst in the past week, the least in the past week, on average, and then currently. Each item is scored separately and higher scores indicate greater pain severity. There are then 12 daily activities in which the participants rates on a scale of 0-10 regarding how much the pain interferes with the activity (10 being the highest interference). These are all scored separately.
Secondary Outcomes
- Satisfaction with Life Scale(Administered at baseline, 5 weeks post-baseline, and 1 month and 6-month follow-ups)
- Health care utilization(Measured 6 months before and 6 months after study enrollment)
- Pain Catastrophizing Scale(Administered at baseline, 5 weeks post-baseline, and 1 month and 6-month follow-ups)
- Insomnia Severity Index(Administered at baseline, 5 weeks post-baseline, and 1 month and 6-month follow-ups)